Transvenous pacing lead-induced superior vena cava syndrome: What do we know?




The use of transvenous pacing in the treatment of bradyarrhythmia imposes risk of the development of superior vena cava syndrome especially when associated with multiple retained leads and infective endocarditis. Percutaneous leads extraction and stenting in this group of patients is of high risk. We report a case of pacing wire-induced superior vena cava syndrome necessitating surgical lead removal and review the literature to evaluate predictive factors favouring surgical treatment.